Sandeep Divate Sathyanarayana
Research Subjects
Sandeep Divate Sathyanarayana has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anoop Narayanan Vadakkepushpakath
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore, Karnataka-575018, India
2 shared publications - Ravi Gundadka Shriram
Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore 575018, Karnataka, India
2 shared publications - Dipti H. Patel
Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Parul University, P.O. Limda, Tal. Waghodia-391760, India
1 shared publication - H K Pradeep
Department of Pharmaceutics, Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Parul University, P.O. Limda, Tal. Waghodia-391760, India
1 shared publication - H. Parimala
Department of Pharmaceutics, GM Institute of Pharmaceutical Sciences and Research, Davangere-577006, India
1 shared publication - Jobin Jose
Department of Pharmaceutics, Nitte (Deemed to be University) NGSM Institute of Pharmaceutical Sciences Mangalore India
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
FORMULATION, OPTIMIZATION AND CHARACTERIZATION OF BACLOFEN-LOADED LIPOSOMES FOR TOPICAL APPLICATION USING A QUALITY BY DESIGN APPROACH
Objective: The current study aimed to develop and optimize a liposomal gel for topical baclofen delivery to enhance skin permeation and therapeutic efficacy in muscle spasticity. Methods: A thin film hydration approach was used to create liposomes loaded with Baclofen. To optimize the baclofen liposomes, the effects of lipid concentration and hydration volume on vesicle size and entrapment efficiency were examined using a 32 full factorial design. A topical liposomal gel was created by incorporating an optimized baclofen liposome batch into a 1% Carbopol gel, and it was assessed for many parameters. Results: The optimized formulation demonstrated a mean vesicle size of 244.6 ± 3.34 with a PDI of 0.145 and an entrapment efficiency of 63.78 ± 2.66. The values from the experiments were very close to the predicted values given by the software, with a result error of ±5%, confirming the reliability of the statistical model at 95% confidence interval. A zeta potential of -28.8 mV for optimized formulation reflected good physical stability. The formulated liposomes were found to have a smooth surface texture with discrete particles in spherical shape as demonstrated in TEM analysis. The release profile of the drug from the liposomal gel formulation has shown a sustained release pattern up to 8 hrs with maximum release of 96.95%, following the Higuchi drug release kinetics model with non-Fickian diffusion as predicted by Kores-Peppas model. The in vivo skin irritation test conducted on Wistar rats revealed no signs of irritation. Furthermore, the histopathological evaluation established the safety of the formulation for topical application. Conclusion: It was concluded that the Baclofen-loaded topical liposomal gel represents a promising drug delivery approach for the treatment of muscle spasticity.
- 27 February 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
Open AccessFORMULATION, OPTIMIZATION AND CHARACTERIZATION OF BACLOFEN-LOADED LIPOSOMES FOR TOPICAL APPLICATION USING A QUALITY BY DESIGN APPROACH
Objective: The current study aimed to develop and optimize a liposomal gel for topical baclofen delivery to enhance skin permeation and therapeutic efficacy in muscle spasticity. Methods: A thin film hydration approach was used to create liposomes loaded with Baclofen. To optimize the baclofen liposomes, the effects of lipid concentration and hydration volume on vesicle size and entrapment efficiency were examined using a 32 full factorial design. A topical liposomal gel was created by incorporating an optimized baclofen liposome batch into a 1% Carbopol gel, and it was assessed for many parameters. Results: The optimized formulation demonstrated a mean vesicle size of 244.6 ± 3.34 with a PDI of 0.145 and an entrapment efficiency of 63.78 ± 2.66. The values from the experiments were very close to the predicted values given by the software, with a result error of ±5%, confirming the reliability of the statistical model at 95% confidence interval. A zeta potential of -28.8 mV for optimized formulation reflected good physical stability. The formulated liposomes were found to have a smooth surface texture with discrete particles in spherical shape as demonstrated in TEM analysis. The release profile of the drug from the liposomal gel formulation has shown a sustained release pattern up to 8 hrs with maximum release of 96.95%, following the Higuchi drug release kinetics model with non-Fickian diffusion as predicted by Kores-Peppas model. The in vivo skin irritation test conducted on Wistar rats revealed no signs of irritation. Furthermore, the histopathological evaluation established the safety of the formulation for topical application. Conclusion: It was concluded that the Baclofen-loaded topical liposomal gel represents a promising drug delivery approach for the treatment of muscle spasticity.
- Open Access
- 30 November 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (12) , 2931-2946
Overview of Nanocellulose and its Applications: Insights using Scientometric Analysis
This overview explores the versatility and applications of nanocellulose in various technologies, including energy production, biosensors and bioelectronics. It highlights the potential of bioelectronic decals for physiological and health monitoring as well as for the fabrication of flexible light-emitting sheets. Nanocellulose is also crucial in energy storage materials, particularly in solar heat-harvesting technologies and is essential for environmental sustainability because of its catalytic use in water and air purification. The growing need for nanocellulose based sensors in the healthcare and pollution control sectors is emphasized. Furthermore, the study discusses the role of nanocellulose in 3D bioprinting and tissue engineering with the development of printable hydrogels and regenerative medicine. Furthermore, a scientometric analysis based on Scopus data from 2015 to 2024 is conducted to evaluate the research trends in nanocellulose and its applications. The study provides insights into year-wise production, the top 10 contributing authors, their affiliations, leading countries and the most influential journals in the field. By analyzing publication trends and citation metrics, this review offers a comprehensive overview of the research landscape and the evolving impact of nanocellulose in scientific and industrial applications. Nanocellulose is a revolutionary and promising material with immense potential across multiple domains.
- 30 November 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (12) , 2931-2946
Open AccessOverview of Nanocellulose and its Applications: Insights using Scientometric Analysis
This overview explores the versatility and applications of nanocellulose in various technologies, including energy production, biosensors and bioelectronics. It highlights the potential of bioelectronic decals for physiological and health monitoring as well as for the fabrication of flexible light-emitting sheets. Nanocellulose is also crucial in energy storage materials, particularly in solar heat-harvesting technologies and is essential for environmental sustainability because of its catalytic use in water and air purification. The growing need for nanocellulose based sensors in the healthcare and pollution control sectors is emphasized. Furthermore, the study discusses the role of nanocellulose in 3D bioprinting and tissue engineering with the development of printable hydrogels and regenerative medicine. Furthermore, a scientometric analysis based on Scopus data from 2015 to 2024 is conducted to evaluate the research trends in nanocellulose and its applications. The study provides insights into year-wise production, the top 10 contributing authors, their affiliations, leading countries and the most influential journals in the field. By analyzing publication trends and citation metrics, this review offers a comprehensive overview of the research landscape and the evolving impact of nanocellulose in scientific and industrial applications. Nanocellulose is a revolutionary and promising material with immense potential across multiple domains.
- Open Access
- 7 November 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 211-223
FORMULATION AND EVALUATION OF LULICONAZOLE NANOEMULGEL USING BOX-BEHNKEN DESIGN APPROACH
Objective: The present study was aimed to develop and assess a Luliconazole-loaded nano emulgel for topical application. Methods: Nanoemulsion of Luliconazole was prepared by ultrasonication method. A pseudo-ternary phase diagram was constructed to determine the ideal ratio of oil and the surfactant/co-surfactant mixture for nanoemulsion preparation. The Box Behnken statistical design was utilized to optimize the nanoemulsion. The optimized batch of nanoemulsion was incorporated into the 1% Carbopol gel as nanoemulgel. It was evaluated for various parameters like globule size, zeta potential, pH, spreadability, viscosity, drug content, drug release, ex vivo permeation study, in vivo animal skin irritation study, and histopathology studies. Results: The optimized formulation showed a globule size of 130.5 nm and entrapment efficiency of 80% and the values were found to be within±5% of predicted values, indicating the suggested statistical model was significant at 95% of confidence interval. The zeta potential of the formulation was found to be-22.1 mV, indicating enhanced stability of the formulation. Transmission Electron Microscopy (TEM) images revealed that the formulation had a smooth surface texture with a mean globule size meeting the nanoscale size range. The drug release study demonstrated a sustained release pattern for the formulation, with a maximum release of 74.93±0.8% over 8 h. The formulated gel exhibited appreciable ex vivo permeability. An in vivo skin irritation test on Wister rats showed no signs of skin irritation from the formulation. The histopathological examination further confirmed that the formulation was dermatologically safe, exhibiting no toxicity or irritation. Conclusion: The results of the present study concluded that Luliconazole-loaded nanoemulgel could be a potential topical drug delivery approach for the management of fungal infections.
- 7 November 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 211-223
Open AccessFORMULATION AND EVALUATION OF LULICONAZOLE NANOEMULGEL USING BOX-BEHNKEN DESIGN APPROACH
Objective: The present study was aimed to develop and assess a Luliconazole-loaded nano emulgel for topical application. Methods: Nanoemulsion of Luliconazole was prepared by ultrasonication method. A pseudo-ternary phase diagram was constructed to determine the ideal ratio of oil and the surfactant/co-surfactant mixture for nanoemulsion preparation. The Box Behnken statistical design was utilized to optimize the nanoemulsion. The optimized batch of nanoemulsion was incorporated into the 1% Carbopol gel as nanoemulgel. It was evaluated for various parameters like globule size, zeta potential, pH, spreadability, viscosity, drug content, drug release, ex vivo permeation study, in vivo animal skin irritation study, and histopathology studies. Results: The optimized formulation showed a globule size of 130.5 nm and entrapment efficiency of 80% and the values were found to be within±5% of predicted values, indicating the suggested statistical model was significant at 95% of confidence interval. The zeta potential of the formulation was found to be-22.1 mV, indicating enhanced stability of the formulation. Transmission Electron Microscopy (TEM) images revealed that the formulation had a smooth surface texture with a mean globule size meeting the nanoscale size range. The drug release study demonstrated a sustained release pattern for the formulation, with a maximum release of 74.93±0.8% over 8 h. The formulated gel exhibited appreciable ex vivo permeability. An in vivo skin irritation test on Wister rats showed no signs of skin irritation from the formulation. The histopathological examination further confirmed that the formulation was dermatologically safe, exhibiting no toxicity or irritation. Conclusion: The results of the present study concluded that Luliconazole-loaded nanoemulgel could be a potential topical drug delivery approach for the management of fungal infections.
- 1 June 2020
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 17 (3) , 259-264
Microemulsion Based Gel of Sulconazole Nitrate for Topical Application
Sulconazole is a broad spectrum antifungal agent of the imidazole class used against dermatophytes and other fungi to treat skin infections. The aim of the present work was to formulate and evaluate a microemulsion-based topical sulconazole gel. Microemulsion formulation of sulconazole nitrate was prepared by using oil, surfactant, cosurfactant and water at different ratios. This was then subjected to clarity and particle size analysis, a centrifugation test, a dilution test, and freeze thawing. The zeta potential of formulation F1 was -41.3 and stable. The pH of the microemulsion formulation was within the range of pH of skin. F1 showed a higher percentage amount of drug as compared with the other formulations. The viscosity showed that F1 was optimum. The freezing and thawing results showed there was no phase separation and the formulation was stable. In vitro drug release showed that the drug release from the microemulsion of F1 was higher when compared to the other formulations. It revealed F1 had the highest drug content of 95.88±0.3% and % cumulative drug release was 88.75% release in 8 h. The in vivo skin irritation study on rats confirmed that formulation was nontoxic and nonirritant. The present study confirmed the safety of the formulated sulconazole loaded microemulsion gel for topical application.
- 1 June 2020
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 17 (3) , 259-264
Microemulsion Based Gel of Sulconazole Nitrate for Topical Application
Sulconazole is a broad spectrum antifungal agent of the imidazole class used against dermatophytes and other fungi to treat skin infections. The aim of the present work was to formulate and evaluate a microemulsion-based topical sulconazole gel. Microemulsion formulation of sulconazole nitrate was prepared by using oil, surfactant, cosurfactant and water at different ratios. This was then subjected to clarity and particle size analysis, a centrifugation test, a dilution test, and freeze thawing. The zeta potential of formulation F1 was -41.3 and stable. The pH of the microemulsion formulation was within the range of pH of skin. F1 showed a higher percentage amount of drug as compared with the other formulations. The viscosity showed that F1 was optimum. The freezing and thawing results showed there was no phase separation and the formulation was stable. In vitro drug release showed that the drug release from the microemulsion of F1 was higher when compared to the other formulations. It revealed F1 had the highest drug content of 95.88±0.3% and % cumulative drug release was 88.75% release in 8 h. The in vivo skin irritation study on rats confirmed that formulation was nontoxic and nonirritant. The present study confirmed the safety of the formulated sulconazole loaded microemulsion gel for topical application.
- Open Access
- 1 January 2020
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 9 (2) , 69-75
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Sathyanarayana SD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):69-75. https://doi.org/10.7774/cevr.2020.9.2.69
- 1 January 2020
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 9 (2) , 69-75
Open AccessVaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Sathyanarayana SD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):69-75. https://doi.org/10.7774/cevr.2020.9.2.69